Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47.6M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
31.7M
-
Shares change
-
-1.22M
-
Total reported value, excl. options
-
$50.1M
-
Value change
-
-$2.25M
-
Put/Call ratio
-
0
-
Number of buys
-
9
-
Number of sells
-
-22
-
Price
-
$1.58
Significant Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q1 2025
49 filings reported holding EPIX - ESSA Pharma Inc. - Common Shares, no par value per share as of Q1 2025.
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.7M shares
of 47.6M outstanding shares and own 66.56% of the company stock.
Largest 10 shareholders include BVF INC/IL (8.75M shares), TANG CAPITAL MANAGEMENT LLC (4.3M shares), MORGAN STANLEY (4.3M shares), BML Capital Management, LLC (4.22M shares), Soleus Capital Management, L.P. (2.26M shares), Opaleye Management Inc. (2.21M shares), Pfizer Inc (1.68M shares), Altium Capital Management LLC (1.05M shares), BANK OF AMERICA CORP /DE/ (698K shares), and Aldebaran Capital, LLC (569K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.